Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report.
Puig-Casadevall M, Álvarez-Bravo G, Varela AQ, Robles-Cedeño R, Sànchez Cirera L, Miguela A, Laguillo G, Montalban X, Hauser SL, Ramió-Torrentà L. Puig-Casadevall M, et al. Among authors: alvarez bravo g. Eur J Neurol. 2023 Oct;30(10):3357-3361. doi: 10.1111/ene.15988. Epub 2023 Jul 31. Eur J Neurol. 2023. PMID: 37485841
Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis.
Coll-Martinez C, Quintana E, Salavedra-Pont J, Buxó M, González-Del-Rio M, Gómez I, Muñoz-San Martín M, Villar LM, Álvarez-Bravo G, Robles-Cedeño R, Ramió-Torrentà L, Gich J. Coll-Martinez C, et al. Among authors: alvarez bravo g. Brain Behav. 2021 Dec;11(12):e2405. doi: 10.1002/brb3.2405. Epub 2021 Nov 18. Brain Behav. 2021. PMID: 34796675 Free PMC article.
Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors.
Coll-Martinez C, Salavedra-Pont J, Buxó M, Quintana E, Quiroga-Varela A, Robles-Cedeño R, Puig M, Álvarez-Bravo G, Ramió-Torrentà L, Gich J. Coll-Martinez C, et al. Among authors: alvarez bravo g. Front Psychol. 2023 Aug 23;14:1163112. doi: 10.3389/fpsyg.2023.1163112. eCollection 2023. Front Psychol. 2023. PMID: 37680235 Free PMC article.
PET coregistered with MRI imaging of anti-NMDAR encephalitis patient with SARS-CoV-2 infection.
Mestre Fusco A, Beltrán Mármol B, Álvarez Bravo G, Ferran Sureda N, Negre Busó M, Rubió Rodríguez A. Mestre Fusco A, et al. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 Aug 19;41:S46-7. doi: 10.1016/j.remn.2021.07.003. Online ahead of print. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021. PMID: 34489207 Free PMC article. English, Spanish. No abstract available.
Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection.
Álvarez Bravo G, Ramió I Torrentà L. Álvarez Bravo G, et al. Neurologia (Engl Ed). 2020 Nov-Dec;35(9):699-700. doi: 10.1016/j.nrl.2020.07.013. Epub 2020 Aug 3. Neurologia (Engl Ed). 2020. PMID: 32912742 Free PMC article. No abstract available.
Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Villacieros-Álvarez J, Lunemann JD, Sepulveda M, Valls-Carbó A, Dinoto A, Fernández V, Vilaseca A, Castillo M, Arrambide G, Bollo L, Espejo C, Llufriu S, Blanco Y, Armangue T, Álvarez Bravo G, Quiroga-Varela A, Ramió Torrentà L, Cobo-Calvo A, Tintore M, Mariotto S, Montalban X, Comabella M. Villacieros-Álvarez J, et al. Among authors: alvarez bravo g. Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200340. doi: 10.1212/NXI.0000000000200340. Epub 2024 Dec 11. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39661937 Free PMC article.
19 results